The large number of people who attended the European Medicines Agency’s first workshop on advanced therapy medicinal products reflects the interest of stakeholders for this rapidly evolving field. Around 160 individuals from regulatory authorities, industry and academia attended the much anticipated meeting, which took place in London on 3 April, a month after having been postponed due to severe weather conditions
...
Please Login to read the full article.
